Form 4: Moelis & Co. Executive Navid Mahmoodzadegan Reports Acquisition of Incentive RSUs

Sentiment:

SEC Form 4 Filing


Navid Mahmoodzadegan, Co-President and MD of Moelis & Co, reports the acquisition of incentive Restricted Stock Units (RSUs) as dividend equivalents.

Summary

  • On September 26, 2024, Navid Mahmoodzadegan, Co-President and Managing Director of Moelis & Co, reported acquiring 486.13 incentive Restricted Stock Units (RSUs).
  • These RSUs were issued as dividend equivalents on unvested underlying incentive RSUs issued on February 13, 2020.
  • The dividend equivalent incentive RSUs will vest concurrently with the vesting of the unvested underlying incentive RSUs.
  • Following the transaction, Mahmoodzadegan beneficially owns 56,561.32 derivative securities.
  • Each RSU represents the right to receive either a share of Class A common stock or an equivalent amount of cash, at Moelis & Company's option.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs as dividend equivalents is a routine part of executive compensation and aligns management interests with shareholders.

Positives

  • The acquisition of dividend equivalent RSUs suggests continued alignment of executive compensation with shareholder value.

Future Outlook

The vesting of the RSUs is tied to the vesting schedule of the underlying incentive RSUs, aligning executive compensation with long-term performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

  • The acquisition of RSUs aligns the executive's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
February 13, 2020Date of issuance of the underlying unvested Incentive RSUs on which the dividend equivalents were issued.
September 26, 2024Date of the transaction: acquisition of incentive RSUs as dividend equivalents.
September 30, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.